Researchers from around the country convened in Chapel Hill April 11-12 for UNC Lineberger’s Scientific Symposium to hear the latest research into molecularly targeted treatments for cancer. More than 440 […]
Join participants from across the country – pancreatic cancer survivors, caregivers and volunteers – as we advocate for increased funding for pancreatic cancer research. It’s time to tell Congress that together, we can make the impossible possible for patients everywhere!
Kirsten Bryant, PhD, a cancer researcher and postdoctoral fellow at the UNC Lineberger Comprehensive Cancer Center, and Channing Der, PhD, a UNC Lineberger member and the Sarah Graham Kenan Professor […]
Dr. Channing Der and the rest of the lab were featured in an article on the Carolina Scientific blog. The article highlights the science the lab is developing as well […]
Meagan Ryan, graduate student in the Der and Cox Labs and CCBTP trainee, has been selected to receive a Women in Cancer Research (WICR) Scholar Award. These awards are given […]
Dr. Channing Der served as a thesis opponent to Arafath Kaja Najumudeen today at the Abo Akademi University in Turku, Finland. Arafath completed his PhD studies on the Ras oncogene.
University of North Carolina Lineberger Comprehensive Cancer Center researchers have found a promising strategy that may limit the growth of pancreatic cancers in patients with a mutation in a gene […]
GRANTEE: KIRSTEN BRYANT, PHD University of North Carolina at Chapel Hill Research Project: Exploiting pancreatic cancer cell metabolism for therapeutic gain Award: 2015 Pancreatic Cancer Action Network – AACR Pathway to […]
A research team led by Drs. Adrienne D. Cox and Channing J. Der (members of the UNC Lineberger Program in Molecular Therapeutics) is one of the first recipients of an […]
Channing Der awarded NCI grant to pursue drug discovery Channing J. Der, PhD, UNC Lineberger member and Kenan Distinguished Professor in the Department of Pharmacology at the UNC School of […]